(MedPage Today) — JN.1-targeted mRNA boosters developed for the 2024-2025 COVID-19 season were effective and safe in Danish seniors, according to two register-based cohort studies that suggested Europe may have selected the better vaccine strain…
Source link : https://www.medpagetoday.com/infectiousdisease/covid19vaccine/116826
Author :
Publish date : 2025-08-04 21:34:00
Copyright for syndicated content belongs to the linked Source.
